This is a preview of subscription content, log in via an institution to check access.
References
Abe M, Nakai H, Tabata R, et al. Effect of 5-3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino] propoxy-1,3-benzodioxole HCl (MKC-242), a novel 5-HT1A-receptor agonist, on aggressive behaviour and marble burying in mice. Jpn J Pharmacol 1998 Mar; 76: 297–304
Abe M, Tabata R, Saito K-I, et al. Novel benzodioxan derivative, 5-(3-(((2S)-1,4-benzodioxan-2-ylmethyl)amino)propoxyl-1,3-benzodioxole HC1 (MKC-242), with anxiolytic-like and antidepressant-like effects in animal models. J Pharmacol Exp Ther 1996 Aug; 278: 898–905
Matsuda T, Yoshikawa T, Suzuki M, et al. Novel benzodioxan derivative, 5-(3-(((2S)-1,4-benzodioxan-2ylmethyl)amino)-propoxy)-1,3-benzodioxole HC1 (MKC-242), with a highly potent and selective agonist activity at rat central serotonin-1A receptors. Jpn J Pharmacol 1995 Dec; 69: 357–66
Matsuda T, Somboonthum P, Suzuki M, et al. Antidepressantlike effect by postsynaptic 5-HT1A receptor activation in mice. Eur J Pharmacol 1995 Jul 4; 280: 235–8
Abe M, Saito K-I. Reduction of wrap restraint stress-induced defecation by MKC-242, a novel benzodioxan derivative, via 5-HT1A-receptor agonist action in rats. Jpn J Pharmacol 1998 Jul; 77: 211–7
Rights and permissions
About this article
Cite this article
MKC 242. Drugs R&D 2, 53–54 (1999). https://doi.org/10.2165/00126839-199902010-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00126839-199902010-00016